11/26/2021  6:59:51 PM Chg. -1.04 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
159.25USD -0.65% 224,476
Turnover: 35.88 mill.
-Bid Size: - -Ask Size: - 419.14 bill.USD 2.50% 28.48

Business description

Johnson & Johnson and its subsidiaries (the "Company") have employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the health care field. Johnson & Johnson is a holding company, which has more than 250 operating companies conducting business in virtually all countries of the world. The Company’s primary focus is products related to human health and well-being. Johnson & Johnson was incorporated in the State of New Jersey in 1887.
 

Management board & Supervisory board

CEO
Alex Gorsky (bis 3.01.2022)
Management board
Joseph Wolk, Ashley McEvoy, Dr. Peter M. Fasolo, Jennifer Taubert, Joaquin Duato (CEO ab 3.01.2022), Kathryn E. Wengel, Michael H. Ullmann, Michael Sneed, Paulus Stoffels, M.D. (bis 31.12.2021), Thibaut Mongon
Supervisory board
Alex Gorsky, A. Eugene Washington, M.D., Anne M. Mulcahy, Charles Prince, D. Scott Davis, Dr. Jennifer A. Doudna, Dr. Mary Beckerle, Dr. Nadja West, Hubert Joly, Ian E. L. Davis, Marillyn A. Hewson, Mark A. Weinberger, Mark B. McClellan, Ronald A. Williams
 

Company data

Name: Johnson & Johnson
Address: One Johnson & Johnson Plaza,,New Brunswick, New Jersey 08933, USA
Phone: +1-732-524-0400
Fax: -
E-mail: -
Internet: www.jnj.com
Industry: Consumer Goods
Sector: Cosmetics
Sub sector: Cosmetics
End of financial year: 12/31
Free Float: 78.67%
IPO date: -

Investor relations

Name: Jennifer McIntyre
IR phone: +1-800-950-5089
IR Fax: -
IR e-mail: investor.relations@its.jnj.com

Company calendar

CW 50 | 12/7/2021 Dividend Payment
 

Main Shareholders

Freefloat
 
78.67%
The Vanguard Group, Inc.
 
8.66%
BlackRock, Inc.
 
7.20%
State Street Corporation
 
5.47%